SPR-741

N/A

Report date: 2025/06/18 11:34:36
NME

Base Information

Drug NameSPR-741
Drug Alias NameNAB-741SPR-741
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial outer membrane proteins inhibitors
TargetsBacterial outer membrane proteins
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNorthern Antibiotics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEverest Medicines (Suzhou) IncProkaryotics IncEvotec (UK) Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A